{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:13:29Z","timestamp":1791486809994,"version":"4.3.4"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00127-025-03018-8","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:30:36Z","timestamp":1764084636000},"page":"343-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical outcomes in first-episode schizophrenia: identifying predictors of relapse"],"prefix":"10.1007","volume":"61","author":[{"given":"Mulualem","family":"Kelebie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getasew","family":"Kibralew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setegn","family":"Fentahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gidey","family":"Rtbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekidem","family":"Aderaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondale","family":"Endeshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitiku","family":"Belachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulu","family":"Muche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girum","family":"Nakie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kindye","family":"Tesfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girmaw Medfu","family":"Takelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebresilassie","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"3018_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, D. and, American Psychiatric D, Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5, vol 5. American psychiatric association Washington, DC","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"2","key":"3018_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1176\/appi.ps.201400316","volume":"67","author":"D Berg\u00e9","year":"2016","unstructured":"Berg\u00e9 D et al (2016) Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study. Psychiatric Serv 67(2):227\u2013233","journal-title":"Psychiatric Serv"},{"issue":"14","key":"3018_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1177\/070674370505001403","volume":"50","author":"TH Jobe","year":"2005","unstructured":"Jobe TH, Harrow M (2005) Long-term outcome of patients with schizophrenia: a review. Can J Psychiatry 50(14):892\u2013900","journal-title":"Can J Psychiatry"},{"key":"3018_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.schres.2022.11.010","volume":"250","author":"I-M Molstrom","year":"2022","unstructured":"Molstrom I-M et al (2022) The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies. Schizophr Res 250:152\u2013163","journal-title":"Schizophr Res"},{"key":"3018_CR5","doi-asserted-by":"crossref","unstructured":"Pellegrini L, Albert U (2024) Personal recovery in people with mental disorders: the achievement of a meaningful Life, in Social determinants of mental health. Springer, pp 321\u2013341","DOI":"10.1007\/978-3-031-70165-8_21"},{"issue":"3","key":"3018_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/prj0000444","volume":"44","author":"NA Dell","year":"2021","unstructured":"Dell NA, Long C, Mancini MA (2021) Models of mental health recovery: an overview of systematic reviews and qualitative meta-syntheses. Psychiatr Rehabil J 44(3):238","journal-title":"Psychiatr Rehabil J"},{"key":"3018_CR7","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v40.3.01","author":"K Witkiewitz","year":"2020","unstructured":"Witkiewitz K et al (2020) <Emphasis Type=\"Italic\">What is recovery?<\/Emphasis>. Alcohol Res Curr Rev. https:\/\/doi.org\/10.35946\/arcr.v40.3.01","journal-title":"Alcohol Res Curr Rev"},{"issue":"6","key":"3018_CR8","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","volume":"39","author":"E J\u00e4\u00e4skel\u00e4inen","year":"2013","unstructured":"J\u00e4\u00e4skel\u00e4inen E et al (2013) A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 39(6):1296\u20131306","journal-title":"Schizophr Bull"},{"issue":"3","key":"3018_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bs.3830140302","volume":"14","author":"G Langfeldt","year":"1969","unstructured":"Langfeldt G (1969) Schizophrenia: diagnosis and prognosis. Behav Sci 14(3):173\u2013182","journal-title":"Behav Sci"},{"issue":"6","key":"3018_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00131746-200511000-00003","volume":"11","author":"SC Burton","year":"2005","unstructured":"Burton SC (2005) Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use. J Psychiatric Practice\u00ae 11(6):369\u2013378","journal-title":"J Psychiatric Practice\u00ae"},{"issue":"9","key":"3018_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/14656566.2021.1882996","volume":"22","author":"M Curto","year":"2021","unstructured":"Curto M et al (2021) Improving adherence to Pharmacological treatment for schizophrenia: a systematic assessment. Expert Opin Pharmacother 22(9):1143\u20131155","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"3018_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/14656566.2023.2181073","volume":"24","author":"PM Haddad","year":"2023","unstructured":"Haddad PM, Correll CU (2023) Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges. Expert Opin Pharmacother 24(4):473\u2013493","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"3018_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S2215-0366(18)30090-7","volume":"5","author":"CL Hui","year":"2018","unstructured":"Hui CL et al (2018) Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial. Lancet Psychiatry 5(5):432\u2013442","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"3018_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.psychres.2008.06.043","volume":"175","author":"S-H Lee","year":"2010","unstructured":"Lee S-H et al (2010) Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving Risperidone via long-acting injection. Psychiatry Res 175(3):195\u2013199","journal-title":"Psychiatry Res"},{"issue":"12","key":"3018_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","volume":"132","author":"JM Davis","year":"1975","unstructured":"Davis JM (1975) Overview: maintenance therapy in psychiatry: I. schizophrenia. Am J Psychiatry 132(12):1237\u20131245","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3018_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1469-7610.2004.00213.x","volume":"45","author":"JR Asarnow","year":"2004","unstructured":"Asarnow JR, Tompson MC, McGrath EP (2004) Annotation: childhood-onset schizophrenia: clinical and treatment issues. J Child Psychol Psychiatry 45(2):180\u2013194","journal-title":"J Child Psychol Psychiatry"},{"key":"3018_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00406-005-0598-2","volume":"256","author":"A \u00dc\u00e7ok","year":"2006","unstructured":"\u00dc\u00e7ok A et al (2006) One year outcome in first episode schizophrenia: predictors of relapse. Eur Arch Psychiatry Clin Neurosci 256:37\u201343","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"3018_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K et al (2013) Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Adv Psychopharmacol 3(4):200\u2013218","journal-title":"Therapeutic Adv Psychopharmacol"},{"issue":"5","key":"3018_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40263-016-0331-x","volume":"30","author":"M \u00c1lvarez-Jim\u00e9nez","year":"2016","unstructured":"\u00c1lvarez-Jim\u00e9nez M et al (2016) Beyond clinical remission in first episode psychosis: thoughts on antipsychotic maintenance vs. guided discontinuation in the functional recovery era. CNS Drugs 30(5):357\u2013368","journal-title":"CNS Drugs"},{"key":"3018_CR20","volume-title":"Staying well after psychosis: A cognitive interpersonal approach to recovery and relapse prevention","author":"A Gumley","year":"2006","unstructured":"Gumley A, Schwannauer M (2006) Staying well after psychosis: A cognitive interpersonal approach to recovery and relapse prevention. John Wiley & Sons"},{"key":"3018_CR21","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jns.2007.01.059","volume":"256","author":"J Halper","year":"2007","unstructured":"Halper J (2007) The psychosocial effect of multiple sclerosis: the impact of relapses. J Neurol Sci 256:S34\u2013S38","journal-title":"J Neurol Sci"},{"key":"3018_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.01.021","author":"M Kelebie","year":"2025","unstructured":"Kelebie M et al (2025) <Emphasis Type=\"Italic\">Risky sexual behavior and associated factors among people with severe mental illness in Africa: a systematic review and meta-analysis.<\/Emphasis>. J Affect Disord. https:\/\/doi.org\/10.1016\/j.jad.2025.01.021","journal-title":"J Affect Disord"},{"issue":"2","key":"3018_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/HRP.0000000000000109","volume":"24","author":"KA Woodberry","year":"2016","unstructured":"Woodberry KA et al (2016) Progress and future directions in research on the psychosis prodrome: a review for clinicians. Harv Rev Psychiatry 24(2):87\u2013103","journal-title":"Harv Rev Psychiatry"},{"key":"3018_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pneurobio.2016.07.004","volume":"152","author":"MS Keshavan","year":"2017","unstructured":"Keshavan MS et al (2017) New drug developments in psychosis: challenges, opportunities and strategies. Prog Neurobiol 152:3\u201320","journal-title":"Prog Neurobiol"},{"issue":"1\u20133","key":"3018_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","volume":"139","author":"M Alvarez-Jimenez","year":"2012","unstructured":"Alvarez-Jimenez M et al (2012) Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 139(1\u20133):116\u2013128","journal-title":"Schizophr Res"},{"issue":"11","key":"3018_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","volume":"8","author":"L Kappos","year":"2009","unstructured":"Kappos L et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8(11):987\u2013997","journal-title":"Lancet Neurol"},{"issue":"9881","key":"3018_CR27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/S0140-6736(13)60951-4","volume":"381","author":"K Morris","year":"2013","unstructured":"Morris K (2013) Revising the declaration of Helsinki. Lancet 381(9881):1889\u20131890","journal-title":"Lancet"},{"issue":"1\u20133","key":"3018_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.schres.2010.10.024","volume":"126","author":"P Masand","year":"2011","unstructured":"Masand P, O\u2019Gorman C, Mandel FS (2011) Clinical global impression of improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of Ziprasidone clinical study data. Schizophr Res 126(1\u20133):174\u2013183","journal-title":"Schizophr Res"},{"issue":"6","key":"3018_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1365-2753.2007.00921.x","volume":"14","author":"M Berk","year":"2008","unstructured":"Berk M et al (2008) The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract 14(6):979\u2013983","journal-title":"J Eval Clin Pract"},{"key":"3018_CR30","first-page":"205","volume-title":"Diagnostic and statistical manual of mental disorders","author":"F EDITION","year":"1980","unstructured":"EDITION F (1980) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC, pp 205\u2013224"},{"issue":"1","key":"3018_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12888-025-06759-7","volume":"25","author":"B Birhan","year":"2025","unstructured":"Birhan B, Rtbey G, Gelaw KA (2025) Relapse and associated factors among psychiatric patients in Africa: a systematic review and meta-analysis. BMC Psychiatry 25(1):333","journal-title":"BMC Psychiatry"},{"key":"3018_CR32","doi-asserted-by":"crossref","unstructured":"Nussbaum AM (2022) The pocket guide to the DSM-5-TR\u2122 diagnostic exam. American Psychiatric Pub","DOI":"10.1176\/appi.books.9781615379767"},{"key":"3018_CR33","unstructured":"Beckmann D et al (2024) Schizophrenia Spectrum and Other Psychotic Disorders. Study Guide to DSM-5-TR\u00ae, : p. 83"},{"issue":"3","key":"3018_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.psc.2012.06.001","volume":"35","author":"R Tandon","year":"2012","unstructured":"Tandon R (2012) The nosology of schizophrenia: toward DSM-5 and ICD-11. Psychiatr Clin North Am 35(3):557\u2013569","journal-title":"Psychiatr Clin North Am"},{"issue":"5","key":"3018_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0004867415608244","volume":"50","author":"NJ Stomski","year":"2016","unstructured":"Stomski NJ, Morrison P, Meyer A (2016) Antipsychotic medication side effect assessment tools: a systematic review. Aust N Z J Psychiatry 50(5):399\u2013409","journal-title":"Aust N Z J Psychiatry"},{"issue":"S1","key":"3018_CR36","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1192\/bjo.2021.315","volume":"7","author":"J Sterritt","year":"2021","unstructured":"Sterritt J (2021) Monitoring side-effects of antipsychotics using the Glasgow antipsychotic side-effect scale. BJPsych Open 7(S1):S106\u2013S107","journal-title":"BJPsych Open"},{"key":"3018_CR37","unstructured":"Poci L (2024) Enhancing medication adherence among individuals with schizophrenia in the Pacific Northwest using motivational interviewing and MARS-10. University of Massachusetts Global"},{"issue":"1","key":"3018_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.22219\/sm.Vol20.SMUMM1.33729","volume":"20","author":"N Syifa","year":"2024","unstructured":"Syifa N et al (2024) Validity and reliability of Mars-10 questionnaire on antipsychotic adherence in schizophrenia patients. Saintika Med 20(1):11\u201320","journal-title":"Saintika Med"},{"issue":"6","key":"3018_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/ijnp\/pyy004","volume":"21","author":"A Tateno","year":"2018","unstructured":"Tateno A et al (2018) Comparison of dopamine D3 and D2 receptor occupancies by a single dose of Blonanserin in healthy subjects: a positron emission tomography study with [11\u00a0C]-(+)-PHNO. Int J Neuropsychopharmacol 21(6):522\u2013527","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"3018_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40501-024-00324-x","volume":"11","author":"T Reynolds de Sousa","year":"2024","unstructured":"Reynolds de Sousa T, Ribeiro M, Novais F (2024) Assessment of innovative Pharmacological targets in schizophrenia. Curr Treat Options Psychiatry 11(3):203\u2013217","journal-title":"Curr Treat Options Psychiatry"},{"issue":"1","key":"3018_CR41","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1038\/s41598-025-85832-3","volume":"15","author":"M Kelebie","year":"2025","unstructured":"Kelebie M et al (2025) Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia. Sci Rep 15(1):4663","journal-title":"Sci Rep"},{"key":"3018_CR42","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S117321","author":"M Solmi","year":"2017","unstructured":"Solmi M et al (2017) <Emphasis Type=\"Italic\">Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review.<\/Emphasis>. Ther Clin Risk Manag. https:\/\/doi.org\/10.2147\/TCRM.S117321","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"3018_CR43","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/s41380-023-02203-y","volume":"28","author":"S Siafis","year":"2023","unstructured":"Siafis S et al (2023) Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis. Mol Psychiatry 28(8):3267\u20133277","journal-title":"Mol Psychiatry"},{"issue":"4","key":"3018_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ph16040603","volume":"16","author":"R Mlambo","year":"2023","unstructured":"Mlambo R et al (2023) Receptors involved in mental disorders and the use of clozapine, chlorpromazine, olanzapine, and Aripiprazole to treat mental disorders. Pharmaceuticals 16(4):603","journal-title":"Pharmaceuticals"},{"key":"3018_CR45","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2165\/00003495-200464230-00006","volume":"64","author":"PL McCormack","year":"2004","unstructured":"McCormack PL, Wiseman LR (2004) Olanzapine: a review of its use in the management of bipolar I disorder. Drugs 64:2709\u20132726","journal-title":"Drugs"},{"key":"3018_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13318-018-0509-3","volume":"44","author":"T Huang","year":"2019","unstructured":"Huang T, Liu Y, Zhang C (2019) Pharmacokinetics and bioavailability enhancement of baicalin: a review. Eur J Drug Metab Pharmacokinet 44:159\u2013168","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"3018_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1517\/17425255.2015.991713","volume":"11","author":"R Mandrioli","year":"2015","unstructured":"Mandrioli R, Protti M, Mercolini L (2015) Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder. Expert Opin Drug Metab Toxicol 11(1):149\u2013174","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"3018_CR48","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.4088\/JCP.19cs13169","volume":"81","author":"G Schoretsanitis","year":"2020","unstructured":"Schoretsanitis G et al (2020) Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American society of clinical psychopharmacology and the therapeutic drug monitoring task force of the arbeitsgemeinschaft f\u00fcr neuropsychopharmakologie und pharmakopsychiatrie. J Clin Psychiatry 81(3):3649","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"3018_CR49","doi-asserted-by":"publisher","first-page":"e067115","DOI":"10.1136\/bmjopen-2022-067115","volume":"13","author":"I Mhaidat","year":"2023","unstructured":"Mhaidat I et al (2023) Effect of cognitive\u2013behavioural therapy on resilience and relapse in adult patients with substance use disorder: a systematic review protocol. BMJ Open 13(5):e067115","journal-title":"BMJ Open"},{"issue":"4","key":"3018_CR50","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1017\/S0954579406060573","volume":"18","author":"RM Post","year":"2006","unstructured":"Post RM, Leverich GS (2006) The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol 18(4):1181\u20131211","journal-title":"Dev Psychopathol"},{"issue":"1","key":"3018_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/schbul\/sbae045","volume":"51","author":"L de Winter","year":"2025","unstructured":"de Winter L et al (2025) Long-term changes in personal recovery and quality of life among patients with schizophrenia spectrum disorders and different durations of illness: a meta-analysis. Schizophr Bull 51(1):37\u201353","journal-title":"Schizophr Bull"},{"issue":"3","key":"3018_CR52","doi-asserted-by":"publisher","first-page":"204380871986569","DOI":"10.1177\/2043808719865693","volume":"10","author":"PD Harvey","year":"2019","unstructured":"Harvey PD, Strassnig MT, Silberstein J (2019) Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment. J Experimental Psychopathol 10(3):2043808719865693","journal-title":"J Experimental Psychopathol"},{"issue":"7644","key":"3018_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","volume":"336","author":"L Wood","year":"2008","unstructured":"Wood L et al (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336(7644):601\u2013605","journal-title":"BMJ"},{"issue":"2","key":"3018_CR54","doi-asserted-by":"publisher","first-page":"e1002742","DOI":"10.1371\/journal.pmed.1002742","volume":"16","author":"OM Dekkers","year":"2019","unstructured":"Dekkers OM et al (2019) COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med 16(2):e1002742","journal-title":"PLoS Med"},{"issue":"4","key":"3018_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","volume":"35","author":"AM Libby","year":"2013","unstructured":"Libby AM et al (2013) Patient-level medication regimen complexity across populations with chronic disease. Clin Ther 35(4):385\u2013398e1","journal-title":"Clin Ther"},{"issue":"6","key":"3018_CR56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/clpt.2014.59","volume":"95","author":"B Vrijens","year":"2014","unstructured":"Vrijens B, Urquhart J (2014) Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin Pharmacol Ther 95(6):617\u2013626","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3018_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","volume":"52","author":"TF Blaschke","year":"2012","unstructured":"Blaschke TF et al (2012) Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 52(1):275\u2013301","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3018_CR58","unstructured":"Saini SD et al (2007) Effect of medication dosing frequency on adherence in chronic diseases."},{"issue":"2","key":"3018_CR59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1017\/S2045796018000495","volume":"28","author":"S Griffiths","year":"2019","unstructured":"Griffiths S, Wood S, Birchwood M (2019) Vulnerability to psychosocial disability in psychosis. Epidemiol Psychiatr Sci 28(2):140\u2013145","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"2","key":"3018_CR60","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.1973.01750320008002","volume":"28","author":"RR Grinker","year":"1973","unstructured":"Grinker RR, Holzman PS (1973) Schizophrenic pathology in young adults: a clinical study. Arch Gen Psychiatry 28(2):168\u2013175","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"3018_CR61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/1516-4446-2014-1539","volume":"37","author":"E Leclerc","year":"2015","unstructured":"Leclerc E et al (2015) Determinants of adherence to treatment in first-episode psychosis: a comprehensive review. Rev Bras Psiquiatr 37(2):168\u2013176","journal-title":"Rev Bras Psiquiatr"},{"issue":"5","key":"3018_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/PRA.0000000000000491","volume":"26","author":"R Lavingia","year":"2020","unstructured":"Lavingia R, Jones K, Asghar-Ali AA (2020) A systematic review of barriers faced by older adults in seeking and accessing mental health care. J Psychiatric Practice\u00ae 26(5):367\u2013382","journal-title":"J Psychiatric Practice\u00ae"},{"issue":"1","key":"3018_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1363459311403945","volume":"16","author":"J Lamb","year":"2012","unstructured":"Lamb J et al (2012) Access to mental health in primary care: a qualitative meta-synthesis of evidence from the experience of people from \u2018hard to reach\u2019groups. Health 16(1):76\u2013104","journal-title":"Health"},{"issue":"5","key":"3018_CR64","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/schbul\/sbt043","volume":"39","author":"DV Jeste","year":"2013","unstructured":"Jeste DV, Maglione JE (2013) Treating older adults with schizophrenia: challenges and opportunities. Schizophr Bull 39(5):966\u2013968","journal-title":"Schizophr Bull"},{"issue":"4","key":"3018_CR65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S2215-0366(15)00003-6","volume":"2","author":"CI Cohen","year":"2015","unstructured":"Cohen CI, Meesters PD, Zhao J (2015) New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry 2(4):340\u2013350","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"3018_CR66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/eip.12412","volume":"11","author":"J Immonen","year":"2017","unstructured":"Immonen J et al (2017) Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis. Early Interv Psychiat 11(6):453\u2013460","journal-title":"Early Interv Psychiat"},{"issue":"5","key":"3018_CR67","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1034\/j.1600-0447.2003.01434.x","volume":"107","author":"D Jeste","year":"2003","unstructured":"Jeste D et al (2003) Aging and outcome in schizophrenia. Acta Psychiatrica Scandinavica 107(5):336\u2013343","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"3018_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00019442-200002000-00003","volume":"8","author":"CI Cohen","year":"2000","unstructured":"Cohen CI et al (2000) Schizophrenia and older adults: an overview: directions for research and policy. Am J Geriatric Psychiatry 8(1):19\u201328","journal-title":"Am J Geriatric Psychiatry"},{"issue":"1","key":"3018_CR69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12888-021-03488-5","volume":"21","author":"MS Ang","year":"2021","unstructured":"Ang MS, Rekhi G, Lee J (2021) Associations of living arrangements with symptoms and functioning in schizophrenia. BMC Psychiatry 21(1):497","journal-title":"BMC Psychiatry"},{"issue":"5","key":"3018_CR70","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/jpm.13043","volume":"31","author":"LJ Chen","year":"2024","unstructured":"Chen LJ et al (2024) Longitudinal association of social isolation and loneliness with physical function among in-patients living with schizophrenia. J Psychiatr Ment Health Nurs 31(5):956\u2013965","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"3018_CR71","volume-title":"Social isolation and loneliness in older adults: Opportunities for the health care system","author":"Sciences, N.A.o.","year":"2020","unstructured":"Sciences, N.A.o. (2020) Social isolation and loneliness in older adults: Opportunities for the health care system. National Academies Press"},{"issue":"2","key":"3018_CR72","first-page":"5","volume":"27","author":"M Greaves","year":"2009","unstructured":"Greaves M, Rogers\u2013Clark C (2009) The experience of socially isolated older people in accessing and navigating the health care system. Australian J Adv Nurs the 27(2):5\u201311","journal-title":"Australian J Adv Nurs the"},{"issue":"5","key":"3018_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1034\/j.1600-0447.2002.02346.x","volume":"106","author":"L Hansson","year":"2002","unstructured":"Hansson L et al (2002) Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings. Acta Psychiatr Scand 106(5):343\u2013350","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"3018_CR74","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.amjcard.2011.05.023","volume":"108","author":"EM Bucholz","year":"2011","unstructured":"Bucholz EM et al (2011) Effect of living alone on patient outcomes after hospitalization for acute myocardial infarction. Am J Cardiol 108(7):943\u2013948","journal-title":"Am J Cardiol"},{"issue":"9340","key":"3018_CR75","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(02)11197-4","volume":"360","author":"P Qin","year":"2002","unstructured":"Qin P, Agerbo E, Mortensen PB (2002) Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers. Lancet 360(9340):1126\u20131130","journal-title":"Lancet"},{"issue":"4suppl","key":"3018_CR76","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1359786810385490","volume":"24","author":"K Hor","year":"2010","unstructured":"Hor K, Taylor M (2010) Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 24(4suppl):81\u201390","journal-title":"J Psychopharmacol"},{"issue":"3","key":"3018_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/PRA.0000000000000860","volume":"31","author":"V Ricci","year":"2025","unstructured":"Ricci V et al (2025) Symptomatic predictors of suicidal behavior in early psychosis: systematic review. J Psychiatric Practice\u00ae 31(3):125\u2013138","journal-title":"J Psychiatric Practice\u00ae"},{"issue":"1\u20132","key":"3018_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-1781(97)00114-5","volume":"73","author":"C Vocisano","year":"1997","unstructured":"Vocisano C, Klein DN, Keefe RS (1997) Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder. Psychiatry Res 73(1\u20132):33\u201345","journal-title":"Psychiatry Res"},{"key":"3018_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780197582718.001.0001","volume-title":"The suicidal crisis: Clinical guide to the assessment of imminent suicide risk","author":"I Galynker","year":"2023","unstructured":"Galynker I (2023) The suicidal crisis: Clinical guide to the assessment of imminent suicide risk. Oxford University Press"},{"issue":"3","key":"3018_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/wps.20567","volume":"17","author":"TS Stroup","year":"2018","unstructured":"Stroup TS, Gray N (2018) Management of common adverse effects of antipsychotic medications. World Psychiatry 17(3):341\u2013356","journal-title":"World Psychiatry"},{"key":"3018_CR81","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S113099","author":"M Dayabandara","year":"2017","unstructured":"Dayabandara M et al (2017) Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat. https:\/\/doi.org\/10.2147\/NDT.S113099","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3018_CR82","unstructured":"Brown EM (2014) Best Practice for Antipsychotic Medication Management in Community Dwelling Older Adults with Schizophrenia."},{"issue":"3","key":"3018_CR83","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/wps.20060","volume":"12","author":"JM Kane","year":"2013","unstructured":"Kane JM, Kishimoto T, Correll CU (2013) Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12(3):216\u2013226","journal-title":"World Psychiatry"},{"key":"3018_CR84","unstructured":"Laera D et al TREATMENT NON-ADHERENCE AND PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC PAIN. MEDITERRANEAN JOURNAL OF CLINICAL PSYCHOLOGY, 2019. 7(SUPPL. N. 2): p. 102\u2013103"},{"issue":"1","key":"3018_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","volume":"61","author":"U Religioni","year":"2025","unstructured":"Religioni U et al (2025) Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina 61(1):153","journal-title":"Medicina"},{"issue":"02","key":"3018_CR86","first-page":"80","volume":"1","author":"A Ghaffar","year":"2024","unstructured":"Ghaffar A (2024) The role of mental health in chronic disease management. J Healthc Syst Innov 1(02):80\u2013103","journal-title":"J Healthc Syst Innov"},{"issue":"1","key":"3018_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/10401230209147398","volume":"14","author":"J Gerlach","year":"2002","unstructured":"Gerlach J (2002) Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria. Ann Clin Psychiatry 14(1):47\u201357","journal-title":"Ann Clin Psychiatry"},{"key":"3018_CR88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euroneuro.2024.02.005","volume":"82","author":"CU Correll","year":"2024","unstructured":"Correll CU et al (2024) Identification and treatment of individuals with childhood-onset and early-onset schizophrenia. Eur Neuropsychopharmacol 82:57\u201371","journal-title":"Eur Neuropsychopharmacol"},{"key":"3018_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fpsyt.2012.00029","volume":"3","author":"NS Vyas","year":"2012","unstructured":"Vyas NS, Gogtay N (2012) Treatment of early onset schizophrenia: recent trends, challenges and future considerations. Front Psychiatry 3:29","journal-title":"Front Psychiatry"},{"issue":"3","key":"3018_CR90","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/wps.20996","volume":"21","author":"CF Reynolds 3rd","year":"2022","unstructured":"Reynolds CF 3rd et al (2022) Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry 21(3):336\u2013363","journal-title":"World Psychiatry"},{"issue":"1","key":"3018_CR91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41537-023-00427-z","volume":"10","author":"M Lundberg","year":"2024","unstructured":"Lundberg M et al (2024) Challenges and opportunities in the diagnosis and treatment of early-onset psychosis: a case series from the youth affective disorders clinic in Stockholm, Sweden. Schizophr 10(1):5","journal-title":"Schizophr"},{"issue":"1","key":"3018_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1467-9450.00002","volume":"38","author":"CM Hultman","year":"1997","unstructured":"Hultman CM, Wieselgren IM, \u00d6hman A (1997) Relationships between social support, social coping and life events in the relapse of schizophrenic patients. Scand J Psychol 38(1):3\u201313","journal-title":"Scand J Psychol"},{"issue":"4","key":"3018_CR93","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/10615800902811065","volume":"22","author":"LJ Phillips","year":"2009","unstructured":"Phillips LJ et al (2009) Strategies used by psychotic individuals to cope with life stress and symptoms of illness: a systematic review. Anxiety Stress Coping 22(4):371\u2013410","journal-title":"Anxiety Stress Coping"},{"issue":"1","key":"3018_CR94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/wps.21160","volume":"23","author":"JB Kirkbride","year":"2024","unstructured":"Kirkbride JB et al (2024) The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry 23(1):58\u201390","journal-title":"World Psychiatry"},{"issue":"6","key":"3018_CR95","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1176\/appi.ajp.2015.15070922","volume":"173","author":"HG Schnack","year":"2016","unstructured":"Schnack HG et al (2016) Accelerated brain aging in schizophrenia: a longitudinal pattern recognition study. Am J Psychiatry 173(6):607\u2013616","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3018_CR96","first-page":"184","volume":"2","author":"ZS Weret","year":"2014","unstructured":"Weret ZS, Mukherjee R (2014) Prevalence of relapse and associated factors in patient with schizophrenia at Amanuel mental specialized Hospital, Addis Ababa, Ethiopia: institution based cross sectional study. Int J Interdisciplinary Multidisciplinary Stud (IJIMS) 2(1):184\u2013192","journal-title":"Int J Interdisciplinary Multidisciplinary Stud (IJIMS)"},{"issue":"1","key":"3018_CR97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13033-021-00464-0","volume":"15","author":"S Moges","year":"2021","unstructured":"Moges S et al (2021) Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at comprehensive specialized hospitals in Amhara region, ethiopia: a cross-sectional study. Int J Mental Health Syst 15(1):42","journal-title":"Int J Mental Health Syst"},{"key":"3018_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-1076-2","volume":"16","author":"M Fikreyesus","year":"2016","unstructured":"Fikreyesus M, Soboka M, Feyissa GT (2016) Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study. BMC Psychiatry 16:1\u201310","journal-title":"BMC Psychiatry"},{"issue":"1","key":"3018_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/targets3010010","volume":"3","author":"R Nasim","year":"2025","unstructured":"Nasim R, Nawaz S, Nasim MT (2025) The effects of antipsychotic drugs and non-pharmacological therapies on schizophrenia. Targets 3(1):10","journal-title":"Targets"},{"issue":"1","key":"3018_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269881119889296","volume":"34","author":"TR Barnes","year":"2020","unstructured":"Barnes TR et al (2020) Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British association for psychopharmacology. J Psychopharmacol 34(1):3\u201378","journal-title":"J Psychopharmacol"},{"issue":"2\u20133","key":"3018_CR101","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","volume":"176","author":"D Novick","year":"2010","unstructured":"Novick D et al (2010) Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 176(2\u20133):109\u2013113","journal-title":"Psychiatry Res"},{"key":"3018_CR102","doi-asserted-by":"crossref","unstructured":"Sacchetti E (2014) Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. Adherence to antipsychotics in schizophrenia. pp 1\u201384","DOI":"10.1007\/978-88-470-2679-7_1"},{"issue":"5","key":"3018_CR103","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly C et al (2016) Royal Australian and new Zealand college of psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian New Z J Psychiatry 50(5):410\u2013472","journal-title":"Australian New Z J Psychiatry"},{"issue":"5","key":"3018_CR104","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.neubiorev.2009.06.005","volume":"34","author":"H Tost","year":"2010","unstructured":"Tost H, Alam T, Meyer-Lindenberg A (2010) Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 34(5):689\u2013700","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"3018_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","volume":"160","author":"S Kapur","year":"2003","unstructured":"Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13\u201323","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3018_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.20809","volume":"20","author":"M Maj","year":"2021","unstructured":"Maj M et al (2021) The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry 20(1):4\u201333","journal-title":"World Psychiatry"},{"key":"3018_CR107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/00023210-200923030-00002","volume":"23","author":"P Thomas","year":"2009","unstructured":"Thomas P et al (2009) Management of patients presenting with acute psychotic episodes of schizophrenia. CNS Drugs 23:193\u2013212","journal-title":"CNS Drugs"},{"issue":"5","key":"3018_CR108","doi-asserted-by":"publisher","first-page":"36608","DOI":"10.4088\/JCP.MY20096AH1C","volume":"82","author":"CU Correll","year":"2021","unstructured":"Correll CU, Howes OD (2021) Treatment-resistant schizophrenia: definition, predictors, and therapy options. J Clin Psychiatry 82(5):36608","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"3018_CR109","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cpr.2006.12.001","volume":"27","author":"C Bolton","year":"2007","unstructured":"Bolton C et al (2007) Developing psychological perspectives of suicidal behaviour and risk in people with a diagnosis of schizophrenia: we know they kill themselves but do we understand why? Clin Psychol Rev 27(4):511\u2013536","journal-title":"Clin Psychol Rev"},{"key":"3018_CR110","unstructured":"Jacobs DG et al (2010) Assessment and treatment of patients with suicidal behaviors. APA Pract Guidelines, 1(183)"},{"issue":"1","key":"3018_CR111","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cbpra.2010.12.005","volume":"19","author":"SS Bhar","year":"2012","unstructured":"Bhar SS, Brown GK (2012) Treatment of depression and suicide in older adults. Cogn Behav Pract 19(1):116\u2013125","journal-title":"Cogn Behav Pract"},{"issue":"13","key":"3018_CR112","first-page":"7S","volume":"50","author":"CP Association","year":"2005","unstructured":"Association CP (2005) Clinical practice guidelines: treatment of schizophrenia. Can J Psychiatry 50(13):7S","journal-title":"Can J Psychiatry"},{"key":"3018_CR113","unstructured":"Campanile KJ (2014) Impacts of the Recovery Movement on Treatment Adherence for Individuals with Schizophrenia Spectrum Disorders."},{"key":"3018_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1744-859X-6-10","volume":"6","author":"M Pompili","year":"2007","unstructured":"Pompili M et al (2007) Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry 6:1\u201322","journal-title":"Ann Gen Psychiatry"},{"issue":"2","key":"3018_CR115","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cbpra.2011.05.003","volume":"19","author":"SS Daniel","year":"2012","unstructured":"Daniel SS, Goldston DB (2012) Hopelessness and lack of connectedness to others as risk factors for suicidal behavior across the lifespan: implications for cognitive-behavioral treatment. Cogn Behav Pract 19(2):288\u2013300","journal-title":"Cogn Behav Pract"},{"key":"3018_CR116","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fpsyt.2018.00567","volume":"9","author":"I Berardelli","year":"2018","unstructured":"Berardelli I et al (2018) Lifestyle interventions and prevention of suicide. Front Psychiatry 9:567","journal-title":"Front Psychiatry"},{"issue":"2","key":"3018_CR117","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1034\/j.1600-0447.2000.102002098.x","volume":"102","author":"LB Merinder","year":"2000","unstructured":"Merinder LB (2000) Patient education in schizophrenia: a review. Acta Psychiatr Scand 102(2):98\u2013106","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"3018_CR118","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ajhg.2019.06.012","volume":"105","author":"M Lam","year":"2019","unstructured":"Lam M et al (2019) Pleiotropic meta-analysis of cognition, education, and schizophrenia differentiates roles of early neurodevelopmental and adult synaptic pathways. Am J Hum Genet 105(2):334\u2013350","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3018_CR119","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/oxfordjournals.schbul.a006936","volume":"28","author":"B Angell","year":"2002","unstructured":"Angell B, Test MA (2002) The relationship of clinical factors and environmental opportunities to social functioning in young adults with schizophrenia. Schizophr Bull 28(2):259\u2013271","journal-title":"Schizophr Bull"},{"key":"3018_CR120","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","volume":"39","author":"S Marwaha","year":"2004","unstructured":"Marwaha S, Johnson S (2004) Schizophrenia and employment: a review. Soc Psychiatry Psychiatr Epidemiol 39:337\u2013349","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"3018_CR121","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/schbul\/sbp046","volume":"35","author":"J Kreyenbuhl","year":"2009","unstructured":"Kreyenbuhl J, Nossel IR, Dixon LB (2009) Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophr Bull 35(4):696\u2013703","journal-title":"Schizophr Bull"},{"issue":"5","key":"3018_CR122","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ps.53.5.565","volume":"53","author":"J Draine","year":"2002","unstructured":"Draine J et al (2002) Role of social disadvantage in crime, joblessness, and homelessness among persons with serious mental illness. Psychiatric Serv 53(5):565\u2013573","journal-title":"Psychiatric Serv"},{"issue":"1","key":"3018_CR123","doi-asserted-by":"publisher","first-page":"e15058","DOI":"10.2196\/15058","volume":"9","author":"A Gumley","year":"2020","unstructured":"Gumley A et al (2020) Early signs monitoring to prevent relapse in psychosis and promote well-being, engagement, and recovery: protocol for a feasibility cluster randomized controlled trial Harnessing mobile phone technology blended with peer support. JMIR Res Protocols 9(1):e15058","journal-title":"JMIR Res Protocols"},{"key":"3018_CR124","first-page":"149","volume":"8","author":"MO Adebiyi","year":"2018","unstructured":"Adebiyi MO et al (2018) Socio-demographic and clinical factors associated with relapse in mental illness. Int J Afr Nurs Sci 8:149\u2013153","journal-title":"Int J Afr Nurs Sci"},{"issue":"6","key":"3018_CR125","first-page":"587","volume":"61","author":"G Chabungbam","year":"2007","unstructured":"Chabungbam G, Avasthi A, Sharan P (2007) Sociodemographic and clinical factors associated with relapse in schizophrenia. J Neuropsychiatry Clin Neurosci 61(6):587\u2013593","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"02","key":"3018_CR126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4236\/ojpsych.2016.62021","volume":"6","author":"A Shrivastava","year":"2016","unstructured":"Shrivastava A et al (2016) Resilience improves neurocognition and treatment outcomes in schizophrenia: a hypothesis. Open J Psychiatry 6(02):173","journal-title":"Open J Psychiatry"},{"issue":"7","key":"3018_CR127","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S2215-0366(22)00121-3","volume":"9","author":"NA Crossley","year":"2022","unstructured":"Crossley NA et al (2022) The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis. Lancet Psychiatry 9(7):565\u2013573","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"3018_CR128","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1192\/bjp.168.6.718","volume":"168","author":"R Macpherson","year":"1996","unstructured":"Macpherson R, Jerrom B, Hughes A (1996) Relationship between insight, educational background and cognition in schizophrenia. Br J Psychiatry 168(6):718\u2013722","journal-title":"Br J Psychiatry"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-025-03018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-025-03018-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-025-03018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:04:09Z","timestamp":1772204649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-025-03018-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3018"],"URL":"https:\/\/doi.org\/10.1007\/s00127-025-03018-8","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All other authors declare no potential competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}